Related Experiment Video
Updated: Jun 6, 2025

Characterization of Leukocyte-platelet Rich Fibrin, A Novel Biomaterial
Published on: September 29, 2015
Platelet-rich fibrin in dentistry
Platelet-Rich Fibrin (PRF) is a safe, autologous biomaterial widely used in dentistry for tissue regeneration. This review highlights PRF
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Dental Applications
Background:
- Platelet-Rich Fibrin (PRF) is a second-generation autologous platelet concentrate.
- PRF contains growth factors and fibrin scaffolds, utilized in regenerative medicine.
- It offers a safe and biocompatible option with fewer adverse effects compared to other concentrates.
Purpose of the Study:
- To review the progress of Platelet-Rich Fibrin (PRF) as a biomaterial in dentistry.
- To highlight the promising applications of PRF in various dental procedures.
- To provide insights into the preparation and classification of PRF.
Main Methods:
- Comprehensive literature search conducted in PubMed, Google Scholar, X-mol, and GeenMedical databases.
- Searched for publications up to October 2024 with no language restrictions.
- Included randomized controlled trials, clinical trials, case series, and systematic reviews focusing on PRF in dentistry.
Main Results:
- PRF demonstrates widespread application in periodontal soft and hard tissue regeneration.
- Effective use of PRF in treating conditions like oral lichen planus and pulpal regeneration.
- Good results are achievable when PRF is applied to specific dental conditions.
Conclusions:
- PRF is a valuable biomaterial in dentistry due to its autologous nature and regenerative potential.
- Further research into PRF derivatives is anticipated to enhance its oral applications.
- PRF offers promising insights for diagnosing and treating various oral diseases.
More Related Videos
06:36PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP
Published on: April 9, 2013
09:13Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
Published on: April 6, 2017
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Clot Retraction and Fibrinolysis
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...